CCM
GILD icon

Carderock Capital Management’s Gilead Sciences GILD Stock Holding History

Carderock Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,195
Closed -$1.18M – 79
2016
Q2 		$1.18M Buy
14,195
+177
+1% +$15.7K 0.63% 50
2016
Q1 		$1.29M Buy
14,018
+748
+6% +$67.5K 0.66% 50
2015
Q4 		$1.34M Buy
+13,270
New +$1.38M 0.7% 49
2015
Q3 		– Sell
-1,925
Closed -$225K – 79
2015
Q2 		$225K Buy
+1,925
New +$210K 0.11% 83

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carderock Capital Management's GILD Position: Q3 2016 in Review

Carderock Capital Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 14,195 shares — an estimated $1.18M sold.

Carderock Capital Management first reported a position in GILD in Q2 2015 and held it in 4 quarters. The position peaked at $1.34M in Q4 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Carderock Capital Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Carderock Capital Management sold 14,195 Gilead Sciences shares in Q3 2016, an estimated $1.18M.
  • Carderock Capital Management first reported a position in Gilead Sciences in Q2 2015 and held it in 4 quarters.
  • Carderock Capital Management's Gilead Sciences position peaked at $1.34M in Q4 2015.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Carderock Capital Management's 13F filing for Q3 2016, filed 2 Nov 2016.